TrianglePUBLICATIONS · 18316794
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2008 Apr 1
- First author
- Chia S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Chia S
- type
- Author
- name
- Gradishar W
- type
- Author
- name
- Mauriac L
- type
- Author
- name
- Bines J
- type
- Author
- name
- Amant F
- type
- Author
- name
- Federico M
- type
- Author
- name
- Fein L
- type
- Author
- name
- Romieu G
- type
- Author
- name
- Buzdar A
- type
- Author
- name
- Robertson JF
- type
- Author
- name
- Brufsky A
- type
- Author
- name
- Possinger K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Chia S
- type
- Author
- name
- Gradishar W
- type
- Author
- name
- Mauriac L
- type
- Author
- name
- Bines J
- type
- Author
- name
- Amant F
- type
- Author
- name
- Federico M
- type
- Author
- name
- Fein L
- type
- Author
- name
- Romieu G
- type
- Author
- name
- Buzdar A
- type
- Author
- name
- Robertson JF
- type
- Author
- name
- Brufsky A
- type
- Author
- name
- Possinger K
- type
- Author
- bibliography ids
- nci-bib-8b6cc22af24e67827e1010eb
- book metadata
- content sha256
- 265ff02bc4179abd1938908c8e6fdce9e659e87998c8970a81f69b46fc790491
- document type
- citation
- dois
- 10.1200/JCO.2007.13.5822
- electronic publication date
- display
- 2008 Mar 3
- precision
- day
- year
- 2008
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:18316794
- immutable id
- pubmed:18316794@265ff02bc4179abd1938908c8e6fdce9e659e87998c8970a81f69b46fc790491
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 10
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1664-70
- volume
- 26
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 18316794
- provenance
- batch id
- e663b4be92ee60a9b059
- provider
- NCBI PubMed ESummary
- record sha256
- 01703df496f1ea6a690692a98429c4f0a4e8e656c6967da522cb2be69f491c24
- response sha256
- 514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
- retrieved at
- 2026-09-09T23:46:19.265979+00:00
- publication date
- display
- 2008 Apr 1
- precision
- day
- year
- 2008
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Preserved source evidence · Not medical advice